Similar articles for PMID: 27660148

Year	Number of Results
2007	1
2011	1
2013	1
2014	3
2015	10
2016	21
2017	30
2018	37
2019	24
2020	26
2021	7
2022	11
2023	3
2024	0

1

⁶⁸Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with ²²³Ra: Proof of Concept.

Ahmadzadehfar H, Azgomi K, Hauser S, Wei X, Yordanova A, Gaertner FC, Kürpig S, Strunk H, Essler M. Ahmadzadehfar H, et al. J Nucl Med. 2017 Mar;58(3):438-444. doi: 10.2967/jnumed.116.178533. Epub 2016 Sep 22. J Nucl Med. 2017. PMID: 27660148 Free article.

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

Diagnostic value of additional ⁶⁸Ga-PSMA-PET before ²²³Ra-dichloride therapy in patients with metastatic prostate carcinoma.

Bräuer A, Rahbar K, Konnert J, Bögemann M, Stegger L. Bräuer A, et al. Nuklearmedizin. 2017 Feb 14;56(1):14-22. doi: 10.3413/Nukmed-0846-16-09. Epub 2017 Jan 11. Nuklearmedizin. 2017. PMID: 28074210

4

68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.

Ahmadzadehfar H, Schlenkhoff CD, Rogenhofer S, Yordanova A, Essler M. Ahmadzadehfar H, et al. Clin Nucl Med. 2016 Sep;41(9):695-6. doi: 10.1097/RLU.0000000000001286. Clin Nucl Med. 2016. PMID: 27405025

5

68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.

Schmidkonz C, Cordes M, Goetz TI, Prante O, Kuwert T, Ritt P, Uder M, Wullich B, Goebell P, Bäuerle T. Schmidkonz C, et al. Ann Nucl Med. 2019 Oct;33(10):766-775. doi: 10.1007/s12149-019-01387-0. Epub 2019 Jul 23. Ann Nucl Med. 2019. PMID: 31338731

6

Detection Efficacy of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria.

Einspieler I, Rauscher I, Düwel C, Krönke M, Rischpler C, Habl G, Dewes S, Ott A, Wester HJ, Schwaiger M, Maurer T, Eiber M. Einspieler I, et al. J Nucl Med. 2017 Jul;58(7):1081-1087. doi: 10.2967/jnumed.116.184457. Epub 2017 Feb 16. J Nucl Med. 2017. PMID: 28209912 Free article.

7

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.

Rauscher I, Maurer T, Beer AJ, Graner FP, Haller B, Weirich G, Doherty A, Gschwend JE, Schwaiger M, Eiber M. Rauscher I, et al. J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3. J Nucl Med. 2016. PMID: 27261524 Free article.

8

Comparison of ⁶⁸Ga-labelled PSMA-11 and ¹¹C-choline in the detection of prostate cancer metastases by PET/CT.

Schwenck J, Rempp H, Reischl G, Kruck S, Stenzl A, Nikolaou K, Pfannenberg C, la Fougère C. Schwenck J, et al. Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):92-101. doi: 10.1007/s00259-016-3490-6. Epub 2016 Aug 24. Eur J Nucl Med Mol Imaging. 2017. PMID: 27557844

9

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, Christidis D, Bolton D, Hofman MS, Lawrentschuk N, Murphy DG. Perera M, et al. Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14. Eur Urol. 2020. PMID: 30773328

10

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.

Henkenberens C, Oehus AK, Derlin T, Bengel F, Ross TL, Kuczyk MA, Janssen S, Christiansen H, von Klot CAJ. Henkenberens C, et al. Strahlenther Onkol. 2020 Nov;196(11):1006-1017. doi: 10.1007/s00066-020-01629-5. Epub 2020 May 12. Strahlenther Onkol. 2020. PMID: 32399639 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year